<VariationArchive RecordType="classified" VariationID="1808956" VariationName="GRCh37/hg19 6q23.2(chr6:133522860-134541311)x1" VariationType="copy number loss" Accession="VCV001808956" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-31" DateCreated="2022-12-31" MostRecentSubmission="2022-12-31">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1865960" VariationID="1808956">
      <GeneList>
        <Gene Symbol="EYA4" FullName="EYA transcriptional coactivator and phosphatase 4" GeneID="2070" HGNC_ID="HGNC:3522" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>6q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="133240593" stop="133532128" display_start="133240593" display_stop="133532128" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="133562494" stop="133853257" display_start="133562494" display_stop="133853257" Strand="+" />
          </Location>
          <OMIM>603550</OMIM>
          <Haploinsufficiency last_evaluated="2020-01-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EYA4">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-01-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EYA4">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SGK1" FullName="serum/glucocorticoid regulated kinase 1" GeneID="6446" HGNC_ID="HGNC:10810" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>6q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="134169256" stop="134318112" display_start="134169256" display_stop="134318112" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="134490383" stop="134639195" display_start="134490383" display_stop="134639195" Strand="-" />
          </Location>
          <OMIM>602958</OMIM>
        </Gene>
        <Gene Symbol="SLC2A12" FullName="solute carrier family 2 member 12" GeneID="154091" HGNC_ID="HGNC:18067" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>6q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="133987581" stop="134052624" display_start="133987581" display_stop="134052624" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="134308718" stop="134373788" display_start="134308718" display_stop="134373788" Strand="-" />
          </Location>
          <OMIM>610372</OMIM>
        </Gene>
        <Gene Symbol="TBPL1" FullName="TATA-box binding protein like 1" GeneID="9519" HGNC_ID="HGNC:11589" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>6q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="133952174" stop="133990432" display_start="133952174" display_stop="133990432" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="134273307" stop="134308637" display_start="134273307" display_stop="134308637" Strand="+" />
          </Location>
          <OMIM>605521</OMIM>
        </Gene>
        <Gene Symbol="TCF21" FullName="transcription factor 21" GeneID="6943" HGNC_ID="HGNC:11632" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>6q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="133889113" stop="133895537" display_start="133889113" display_stop="133895537" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="134210258" stop="134216674" display_start="134210258" display_stop="134216674" Strand="+" />
          </Location>
          <OMIM>603306</OMIM>
        </Gene>
      </GeneList>
      <Name>GRCh37/hg19 6q23.2(chr6:133522860-134541311)x1</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>6q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" innerStart="133522860" innerStop="134541311" display_start="133522860" display_stop="134541311" />
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh37/hg19 6q23.2(chr6:133522860-134541311)x1 AND not provided" Accession="RCV002474801" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-07-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-31" MostRecentSubmission="2022-12-31">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5421491" SubmissionDate="2022-12-28" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="C8593|not provided|copy:1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002772197" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Quest Diagnostics Nichols Institute San Juan Capistrano" OrgID="500110" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The 6q23.2 deletion is expected to cause phenotypic and/or developmental abnormalities based on size and gene content. The deletion involves multiple protein coding genes including the entire EYA4 (OMIM 603550). Haploinsufficiency of EYA4, via truncating variants and deletions, is associated with autosomal dominant deafness-10 with or without dilated cardiomyopathy 1J (OMIM 605362; OMIM 601316; BMC Med Genet. 2019 May 17;20(1):84. PMID: 31101089; Hum Genome Var. 2018 Aug 22;5:23. PMID: 30155266). Further, larger overlapping deletions of this region, which disrupt the EYA4 gene have been identified in patients with structural brain abnormalities, intellectual disability, gross motor delays, short stature, growth delays, as well as hearing loss and dilated cardiomyopathy (Dutrannoyet al. Eur J Med Genet. 2009 Nov-Dec;52(6):450-3. PMID: 19576303; Abeet al. Hum Mutat. 2009 Oct;30(10):E946-55. PMID: 19606496). A recent case study has reported two overlapping deletions involving EYA4 (1.9Mb and 3.7 Mb) in a mother and her daughter, both with typical clinical features of otofaciocervical syndrome (OTFCS), a disorder characterized by a combination of facial dysmorphisms, ear abnormalities with hearing loss, and shoulder girdle anomalies (Ganaet al., Am J Med Genet A. 2018 May; 176(5):1200-1206. PMID: 31379922).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG/ClinGen CNV Guidelines, 2019</Attribute>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Oligo array</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" innerStart="133522860" innerStop="134541311" />
          </Location>
          <AttributeSet>
            <Attribute Type="AbsoluteCopyNumber">1</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12478099</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5421491" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

